ESSA Pharma Inc.
NASDAQ:EPIX
1.76 (USD) • At close January 15, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0 | 0.118 | 0.122 | 0.109 | 0.11 | 0 | 0.034 | 0.046 | 0.066 | 0 | 0 | 0 | 0 |
| Brutowinst
| 0 | -0.118 | -0.122 | -0.109 | -0.11 | 0 | -0.034 | -0.046 | -0.066 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -303.982 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 21.207 | 21.323 | 24.415 | 24.259 | 12.146 | 6.696 | 4.873 | 5.726 | 13.06 | 4.388 | 0.672 | 1.589 | 0.002 |
| Algemene en administratieve kosten
| 0 | 10.789 | 12.545 | 12.775 | 11.374 | 5.473 | 5.929 | 5.141 | 5.644 | 3.701 | 1.042 | 0.349 | 0 |
| Verkoop- en marketingkosten
| 0 | 0.023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.022 | 0 |
| Verkoop-, algemene en administratieve kosten
| 0 | 10.812 | 12.545 | 12.775 | 11.374 | 5.473 | 5.929 | 5.141 | 5.644 | 3.701 | 1.042 | 0.371 | 0 |
| Overige kosten
| 0 | 0 | 1.738 | 0.109 | 0.515 | 0.035 | -0.04 | -0.037 | 0.079 | 1.145 | 0 | 0 | 0 |
| Bedrijfskosten
| 21.207 | 32.134 | 36.96 | 37.144 | 23.52 | 12.169 | 10.802 | 10.867 | 18.704 | 9.234 | 1.737 | 1.373 | 0.002 |
| Bedrijfsresultaat
| 0 | -32.134 | -35.343 | -36.909 | -23.115 | -12.152 | -10.802 | -11.652 | -19.642 | -9.312 | -1.825 | -1.363 | -0.002 |
| Bedrijfsresultaat ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -90,516.129 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 0 | 5.553 | 1.745 | 0.304 | -0.214 | -0.567 | -0.553 | 11.677 | 5.744 | -0.107 | 0.001 | 0.589 | 0 |
| Inkomen voor belasting
| 0 | -26.581 | -35.215 | -36.84 | -23.734 | -10.403 | -11.603 | -4.383 | -12.989 | -8.568 | -1.824 | -1.371 | -0.002 |
| Inkomen voor belasting ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -59,857.143 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | 0.002 | -0.112 | -0.034 | -0.289 | 0.038 | 0.027 | 0.116 | 0.151 | 0.078 | 0.088 | 0 | 0 |
| Nettowinst
| 0 | -26.582 | -35.103 | -36.805 | -23.445 | -10.441 | -11.63 | -4.499 | -13.14 | -8.568 | -1.824 | -1.371 | -0.002 |
| Nettowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -60,552.995 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.64 | -0.6 | -0.8 | -0.96 | -1.04 | -1.24 | -2.55 | -3.09 | -9.77 | -9.34 | -2.33 | -1.75 | -2.65 |
| Verwaterde WPA
| -0.64 | -0.6 | -0.8 | -0.96 | -1.04 | -1.24 | -2.55 | -3.09 | -9.77 | -9.34 | -2.33 | -1.75 | -2.65 |
| EBITDA
| 0 | -26.455 | -35.08 | -36.708 | -23.006 | -12.134 | -10.768 | -3.552 | -18.666 | -9.377 | -1.756 | -1.338 | -0.002 |
| EBITDA ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -85,829.493 | 0 | 0 | 0 | 0 |